1
|
Mok SL, Chuah JY, Lee KJ, Lim YD, Appalasamy JR, Saw PS, Selvaraj A. Community Pharmacists' Views on Their Roles in Mental Health Screening and Management in Malaysia. Community Ment Health J 2024:10.1007/s10597-024-01337-9. [PMID: 39133358 DOI: 10.1007/s10597-024-01337-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/24/2023] [Accepted: 07/29/2024] [Indexed: 08/13/2024]
Abstract
Community pharmacists (CPs) are vital as primary healthcare providers, particularly in the screening and management of mental health issues. This study aimed to explore CPs' views on mental health support for patients and the potential challenges in delivering mental health services. Malaysian CPs were recruited through purposive and snowballing sampling. Semi-structured interviews were recorded and transcribed verbatim. Data was thematically analyzed using NVivo 12 management software. Twenty CPs from Peninsular Malaysia were interviewed. Participants emphasized the importance of high-quality resources, comprehensive training and standardized tools to effectively provide mental healthcare services. Challenges identified were lack of knowledge and skills, absence of screening tools and social stigma and conservatism, particularly among older individuals. This study underscores the willingness of CPs taking a primary role in mental health services. However, collaboration with relevant stakeholders is crucial, aligning with national strategic plans for the program to be successful.
Collapse
Affiliation(s)
- Shien Loong Mok
- School of Pharmacy, Monash University Malaysia, Building 2, Level 5 Jalan Lagoon Selatan, Bandar Sunway, Selangor, 47500, Malaysia
| | - Jing Ying Chuah
- School of Pharmacy, Monash University Malaysia, Building 2, Level 5 Jalan Lagoon Selatan, Bandar Sunway, Selangor, 47500, Malaysia
| | - Kun Jin Lee
- School of Pharmacy, Monash University Malaysia, Building 2, Level 5 Jalan Lagoon Selatan, Bandar Sunway, Selangor, 47500, Malaysia
| | - Yee Dom Lim
- School of Pharmacy, Monash University Malaysia, Building 2, Level 5 Jalan Lagoon Selatan, Bandar Sunway, Selangor, 47500, Malaysia
| | - Jamuna Rani Appalasamy
- School of Pharmacy, Monash University Malaysia, Building 2, Level 5 Jalan Lagoon Selatan, Bandar Sunway, Selangor, 47500, Malaysia
| | - Pui San Saw
- School of Pharmacy, Monash University Malaysia, Building 2, Level 5 Jalan Lagoon Selatan, Bandar Sunway, Selangor, 47500, Malaysia
| | - Amutha Selvaraj
- School of Pharmacy, Monash University Malaysia, Building 2, Level 5 Jalan Lagoon Selatan, Bandar Sunway, Selangor, 47500, Malaysia.
| |
Collapse
|
2
|
McCormack Z, Kerr A, Simpson A, Keating D, Strawbridge J. What works for whom, how and why in mental health education for undergraduate health profession students? A realist synthesis protocol. BMJ Open 2024; 14:e078130. [PMID: 38471690 PMCID: PMC10936517 DOI: 10.1136/bmjopen-2023-078130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Accepted: 02/14/2024] [Indexed: 03/14/2024] Open
Abstract
INTRODUCTION It has been shown that mental health education can support positive attitudes of health profession students towards people with mental health challenges, which supports them to provide optimal healthcare to this group. There are many different approaches to designing and delivering mental health education to health profession students. Each has their own advantages and disadvantages, and often mental health education programmes incorporate a multimodal approach in order to reap the benefits of a variety of teaching and learning approaches. The aim of this study is to understand the current landscape of teaching and learning approaches to mental health education for undergraduate health profession students. We will examine the features of successful outcomes for health profession students for:Learning environment.Knowledge development and retention.Confidence. MOTIVATION Preparedness for professional practice. METHODS For this, a realist synthesis has been chosen in order to review the literature. Realist synthesis lends itself to the review of complex interventions such as mental health education for undergraduate health profession curricula because it seeks to uncover the range of different mechanisms and context configurations that produce different outcomes. Health profession education and education practice, in general, is complex. A patient and public involvement (PPI) group is involved throughout this study and includes undergraduate health profession students, and members of the St John of Gods Hospital Consumers and Carers Council who are involved at every stage of the research. This study will engage with a stakeholder group who will support the refining of the programme theory. ETHICS AND DISSEMINATION Ethical approval has been sought and approved by Royal College of Surgeons, Ireland Ethical Committee (REC number: 212622783). We will aim to write up and publish the full synthesis as a journal article. We will also discuss ways of dissemination outside of academia with our PPI group.
Collapse
Affiliation(s)
- Zoe McCormack
- School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - Aisling Kerr
- School of Pharmacy Practice, Robert Gordon University, Aberdeen, UK
| | - Andrew Simpson
- Library Services, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - Dolores Keating
- School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
- Pharmacy Department, Saint John of God Hospitaller Services, Dublin, Ireland
| | - Judith Strawbridge
- School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
| |
Collapse
|
3
|
Pilbrow S, Staniland L, Uren HV, Shand F, McGoldrick J, Thorp E, MacKrill M, Moullin JC. Evaluation of an online advanced suicide prevention training for pharmacists. Int J Clin Pharm 2023; 45:1203-1211. [PMID: 37702959 PMCID: PMC10600280 DOI: 10.1007/s11096-023-01636-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Accepted: 08/10/2023] [Indexed: 09/14/2023]
Abstract
BACKGROUND With the pharmacist role extending internationally to include health promotion and harm reduction, pharmacists are well-suited to adopt a frontline role within suicide prevention efforts. To maximise their abilities to implement suicide prevention strategies, suicide prevention training is essential to improve pharmacists' knowledge of, attitudes towards, and confidence in pharmacy-based suicide prevention. AIM This study aimed to evaluate the impact of an online Advanced Suicide Prevention Training for Pharmacists and explore how participant feedback may direct training improvements. METHOD One hundred and fifty pharmacists in Tasmania, Australia, completed the training. Of these, 109 participants completed surveys pre-, post- and 6-months post-training to evaluate changes in suicide prevention knowledge, confidence, and attitudes, and explore participants' perceptions of the training. RESULTS Significant improvements were observed in suicide prevention attitudes (F(2, 20) = 4.12, p = 0.032, partial η2 = 0.292), and self-efficacy (F(2, 20) = 7.84, p = 0.003, partial η2 = 0.439), across the three timepoints, with improvements to knowledge and confidence evident between pre- and post-training (p < 0.05). Qualitative data reflected that the training was beneficial in aiding the identification and support of at-risk individuals, however barriers such as the pharmacy setting, personal discomfort, and perceptions of the pharmacist role were identified as impeding the implementation of suicide prevention within pharmacy practice. CONCLUSION Training is an effective means of improving pharmacists' suicide prevention knowledge, confidence, and attitudes. While personal barriers to suicide prevention improved, contextual and social barriers continue to impede pharmacists' implementation of suicide prevention in practice.
Collapse
Affiliation(s)
- Samantha Pilbrow
- School of Population Health, Curtin University, Perth, WA, Australia
| | - Lexy Staniland
- Curtin enAble Institute, Curtin University, Perth, WA, Australia
| | - Hannah V Uren
- School of Population Health, Curtin University, Perth, WA, Australia
| | - Fiona Shand
- Black Dog Institute, Sydney, NSW, Australia
- University of New South Wales, Sydney, NSW, Australia
| | | | - Emily Thorp
- Pharmaceutical Society of Australia Tasmanian Branch, Hobart, TAS, Australia
| | - Monique MacKrill
- The Pharmacy Guild of Australia Tasmanian Branch, Battery Point, TAS, Australia
| | - Joanna C Moullin
- School of Population Health, Curtin University, Perth, WA, Australia.
- Curtin enAble Institute, Curtin University, Perth, WA, Australia.
| |
Collapse
|
4
|
Kamal L, Jacob SA. Pharmacists' Experiences, Perceptions, and Attitudes towards Suicide and Suicide Prevention: A Scoping Review. PHARMACY 2023; 11:pharmacy11010025. [PMID: 36827663 PMCID: PMC9965762 DOI: 10.3390/pharmacy11010025] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2022] [Revised: 01/25/2023] [Accepted: 01/27/2023] [Indexed: 02/01/2023] Open
Abstract
It is important to understand pharmacists' experiences, stigmas, trainings, and attitudes to suicide, as they can affect the way pharmacists interact with at-risk individuals and influence outcomes. The aim of this scoping review is to explore pharmacists' willingness, experiences, and attitudes towards suicide prevention, as well as to examine the impact of suicide prevention training programs. A systemic search was conducted using the following databases: PubMed, EMBASE, CINAHL, PsycINFO, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews. Studies included were from database inception to 31 August 2022, in English, with full-text available. A total of 13 studies were included. Training was a key factor which had an impact on pharmacists' attitudes, experiences, and preparedness to participate in suicide care, with studies revealing the lack of training and the call for more training by pharmacists. Another key factor was closeness to mental illness, which also impacted pharmacists' attitudes and experiences with at-risk patients. More research is needed worldwide to understand the different barriers and facilitators to pharmacist involvement in suicide care. Targeted training programs should also be developed to not only increase knowledge and competence, but also to address stigma related to suicide.
Collapse
|
5
|
Werremeyer A, Frenzel O, Strand MA, Eukel H, Skoy E, Steig J. Improving Community Pharmacist-Delivered Care for Patients With Psychiatric Disorders Filling an Opioid Prescription. Psychiatr Serv 2022; 73:1294-1297. [PMID: 35502518 DOI: 10.1176/appi.ps.202100592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Pharmacists tend to provide care to patients with psychiatric disorders less frequently than to other types of patients, yet patients with psychiatric disorders experience more drug-related problems and use more opioids than those without psychiatric disorders. The Opioid and Naloxone Education (ONE) program equipped pharmacists to screen for opioid misuse and overdose risk and to implement a set of interventions for any patient filling an opioid prescription. Patients with a psychiatric disorder (N=1,980; 24.1% of those screened) were significantly more likely to receive more than one intervention from a ONE program pharmacist than were those without a psychiatric disorder. The use of an objective screening tool and training in stigma reduction and nonjudgmental communication approaches, which are part of the ONE program process, deserve further exploration as ways to increase the frequency of pharmacist-provided education and other critical interventions for patients with psychiatric disorders.
Collapse
Affiliation(s)
- Amy Werremeyer
- Department of Pharmacy Practice (Werremeyer, Strand, Eukel, Skoy, Steig) and Department of Public Health (Frenzel), North Dakota State University, Fargo. Marcela Horvitz-Lennon, M.D., and Kenneth Minkoff, M.D., are editors of this column
| | - Oliver Frenzel
- Department of Pharmacy Practice (Werremeyer, Strand, Eukel, Skoy, Steig) and Department of Public Health (Frenzel), North Dakota State University, Fargo. Marcela Horvitz-Lennon, M.D., and Kenneth Minkoff, M.D., are editors of this column
| | - Mark A Strand
- Department of Pharmacy Practice (Werremeyer, Strand, Eukel, Skoy, Steig) and Department of Public Health (Frenzel), North Dakota State University, Fargo. Marcela Horvitz-Lennon, M.D., and Kenneth Minkoff, M.D., are editors of this column
| | - Heidi Eukel
- Department of Pharmacy Practice (Werremeyer, Strand, Eukel, Skoy, Steig) and Department of Public Health (Frenzel), North Dakota State University, Fargo. Marcela Horvitz-Lennon, M.D., and Kenneth Minkoff, M.D., are editors of this column
| | - Elizabeth Skoy
- Department of Pharmacy Practice (Werremeyer, Strand, Eukel, Skoy, Steig) and Department of Public Health (Frenzel), North Dakota State University, Fargo. Marcela Horvitz-Lennon, M.D., and Kenneth Minkoff, M.D., are editors of this column
| | - Jayme Steig
- Department of Pharmacy Practice (Werremeyer, Strand, Eukel, Skoy, Steig) and Department of Public Health (Frenzel), North Dakota State University, Fargo. Marcela Horvitz-Lennon, M.D., and Kenneth Minkoff, M.D., are editors of this column
| |
Collapse
|
6
|
Pothireddy N, Lavigne JE, Groman AS, Carpenter DM. Developing and evaluating a module to teach suicide prevention communication skills to student pharmacists. CURRENTS IN PHARMACY TEACHING & LEARNING 2022; 14:449-456. [PMID: 35483810 DOI: 10.1016/j.cptl.2022.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/07/2021] [Revised: 01/13/2022] [Accepted: 02/27/2022] [Indexed: 06/14/2023]
Abstract
INTRODUCTION This study aimed to determine whether a brief educational intervention for student pharmacists about individuals who exhibit suicide warning signs improves knowledge and confidence to recognize suicide warning signs, ask about suicide, validate feelings, and expedite referrals. METHODS This longitudinal, observational study was conducted with student pharmacists from two pharmacy schools in 2019. Students completed a suicide prevention module adapted from the Veteran Administration's S.A.V.E. suicide prevention gatekeeper training program (completion rate 67%). The module included a video case of an individual who exhibits suicide warning signs, a brief didactic lecture, and a role-play practice session. Text responses were coded by three independent raters. Students completed a multiple-choice pretest and posttest to assess knowledge and confidence. Paired samples t-tests were calculated to examine changes in students' knowledge and confidence scores. RESULTS Students' (N = 139) confidence and knowledge in recognizing and managing suicide warning signs improved significantly. There was improvement in how many students directly asked about suicide and expedited a referral. Most students (86%) reported planning to incorporate what they learned into practice. CONCLUSIONS In two schools of pharmacy, a brief suicide prevention module was implemented and adapted to the community pharmacy setting, which improved pharmacy students' knowledge and confidence to interact with an individual who exhibits suicide warning signs. S.A.V.E. teaches students how to communicate with an individual in crisis in a way that can be integrated into a busy pharmacy workflow, which may be why students planned to incorporate it into practice.
Collapse
Affiliation(s)
- Nithya Pothireddy
- UNC Eshelman School of Pharmacy, 301 Pharmacy Ln, Chapel Hill, NC 27599, United States.
| | - Jill E Lavigne
- St. John Fisher College Wegmans School of Pharmacy, 3690 East Ave, Rochester, NY 14618, United States.
| | - Aleah S Groman
- St. John Fisher College Wegmans School of Pharmacy, 3690 East Ave, Rochester, NY 14618, United States.
| | - Delesha M Carpenter
- UNC Eshelman School of Pharmacy, 220 Campus Drive, Karpen Hall, CPO 2125, Asheville, NC 28804, United States.
| |
Collapse
|
7
|
Harris SC, Bostwick JR, Werremeyer AB, Goldstone LW, Cates ME, Caley CF. Addressing the Conflict Between Promoting Wellness, Perpetuating Mental Illness Stigma and Making Psychiatric Pharmacy Education Less Intense. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION 2021; 85:8354. [PMID: 34544737 PMCID: PMC8499653 DOI: 10.5688/ajpe8354] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/20/2020] [Accepted: 02/05/2021] [Indexed: 06/13/2023]
Abstract
One in five Americans has a diagnosable mental illness, and pharmacists encounter these patients daily. This commentary addresses the conflict between the profession's wellness movement and its ongoing contribution to mental illness stigma. The need for improved pharmacist wellness is based on the profession's risk for burnout and development of related mental illness. The presence of stigma towards patients with mental illness among pharmacists is multi-factorial and complex. Risk of those within the profession perpetuating mental illness stigma could be diminished by developing pharmacy curricula that provide greater opportunities for students to learn more completely about mental illness, how to effectively engage persons with mental illness, and how to take care of themselves, express vulnerability, and talk about mental illness. While reducing mental illness stigma through curricular revision is best achieved through in-person learning experiences, elective coursework and cocurricular activities may also help achieve this goal. Examples of evidence-based best practices are provided.
Collapse
Affiliation(s)
- Suzanne C Harris
- University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, North Carolina
| | | | - Amy B Werremeyer
- North Dakota State University, School of Pharmacy, Fargo, North Dakota
| | - Lisa W Goldstone
- University of Southern California, School of Pharmacy, Los Angeles, California
| | - Marshall E Cates
- Samford University, McWhorter School of Pharmacy, Birmingham, Alabama
| | - Charles F Caley
- Western New England University, College of Pharmacy and Health Sciences, Springfield, Massachusetts
| |
Collapse
|
8
|
Werremeyer A, Mosher S, Eukel H, Skoy E, Steig J, Frenzel O, Strand MA. Pharmacists' stigma toward patients engaged in opioid misuse: When "social distance" does not mean disease prevention. Subst Abus 2021; 42:919-926. [PMID: 33750283 DOI: 10.1080/08897077.2021.1900988] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Background: Health professionals may stigmatize and prefer social distance from patients with opioid misuse, leading to poorer quality of care provided. The degree to which pharmacists prefer social distance from patients with opioid misuse and opioid use disorder (OUD) is not known. Methods: Pharmacists (n = 187) completed a survey comprised of demographics, attitudinal, and Social Distance Scale (SDS) questions based on a vignette patient who displayed opioid misuse. SDS question responses and total scores (maximum of 30; higher scores representing great preference for social distance) were tallied and associations with attitudes and demographics were examined. Results: Mean SDS total score was 16.32 (range 9-23). More than 59% of respondents had an SDS score >15, indicating overall lack of willingness to interact with the vignette patient. Females had a higher mean SDS score vs male pharmacists (16.58 vs. 15.36, respectively; p = 0.023). Pharmacists were more likely to prefer social distance from the vignette patient in personal situations (i.e. renting a room) than work-related interactions (i.e. providing patient education). Pharmacists with >10 years of experience, those without personal experience with a substance use disorder, those who strongly agreed that patients with OUD require excessive time and effort, and those who agreed that some people lack self-discipline to use prescription pain medication without becoming addicted had significantly higher SDS scores than pharmacists without these characteristics. Conclusions: Pharmacists expressed significant preference for social distance indicating stigmatization of patients with opioid misuse. Pharmacists were comfortable performing pharmacy tasks with patients with opioid misuse, but were less comfortable forming therapeutic relationships, an important tenet of patient-centered care. Efforts are needed to examine contributions to social distance preferences and implement measures to reduce them. Targeting of pharmacists with >10 years' experience and without personal experience with OUD may also be most beneficial.
Collapse
Affiliation(s)
- Amy Werremeyer
- Department of Pharmacy Practice, North Dakota State University, Fargo, North Dakota, USA
| | - Sydney Mosher
- Department of Pharmacy Practice, North Dakota State University, Fargo, North Dakota, USA
| | - Heidi Eukel
- Department of Pharmacy Practice, North Dakota State University, Fargo, North Dakota, USA
| | - Elizabeth Skoy
- Department of Pharmacy Practice, North Dakota State University, Fargo, North Dakota, USA
| | - Jayme Steig
- Quality Health Associates of North Dakota, Minot, North Dakota, USA
| | - Oliver Frenzel
- Department of Pharmacy Practice, North Dakota State University, Fargo, North Dakota, USA
| | - Mark A Strand
- Department of Pharmacy Practice, North Dakota State University, Fargo, North Dakota, USA
| |
Collapse
|
9
|
Antoniou T, Pritlove C, Shearer D, Martins D, Tadrous M, Munro C, Gomes T. A qualitative study of a publicly funded pharmacy-dispensed naloxone program. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2021; 92:103146. [PMID: 33568317 DOI: 10.1016/j.drugpo.2021.103146] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2020] [Revised: 01/26/2021] [Accepted: 01/28/2021] [Indexed: 12/28/2022]
Abstract
AIMS To characterize the experiences of individuals accessing pharmacy-based naloxone and relate these experiences to the risk environments and discourses in which they are embedded. METHODS We conducted a qualitative study using in-depth interviews of 37 adults aged 18 years and over who had accessed pharmacy-dispensed naloxone. Participants were recruited from across Ontario, Canada, and comprised individuals taking opioids for chronic pain, those taking opioids for reasons other than chronic pain, and individuals acquiring naloxone to act as bystanders in an opioid overdose setting. We drew upon risk environment theory to interpret participants' accounts. RESULTS Following analysis and interpretation, we generated five theoretically-informed themes characterizing the experiences of individuals accessing pharmacy-dispensed naloxone: 'intersection of naloxone narrative with pharmacy environment', 'individual risk environment and pharmacy-dispensed naloxone uptake', 'safe spaces: creating an enabling environment for pharmacy-dispensed naloxone', 'individuation: becoming a first responder' and 'beyond naloxone: the macro risk environment'. Specifically, participants described how judgement and stereotyping associated with the broader naloxone narrative can be amplified in the space of the pharmacy, leading to fears of reprisals and strategies to mitigate social risk. In addition, the social construction of naloxone as a drug for 'problematic' opioid use and a lack of pharmacist awareness regarding the risk environments in which opioid use occurs was perceived to limit opportunities for optimizing naloxone distribution and training. Finally, participants described approaches that could create enabling environments in the space of the pharmacy while remaining cognizant of the structural changes required in the macro risk environments of people who take opioids. CONCLUSIONS Despite increasing the availability of naloxone, participants characterized several social and environmental factors that could limit the accessibility of the drug from pharmacies. Strategies to address these factors could create enabling environments within pharmacies that optimize the reach and impact of pharmacy-dispensed naloxone.
Collapse
Affiliation(s)
- Tony Antoniou
- Li Ka Shing Knowledge Institute, Unity Health, Toronto, Ontario, Canada; Department of Family and Community Medicine, Unity Health, Toronto, Ontario, Canada; Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada; Ontario Drug Policy Research Network, Toronto, Ontario, Canada
| | - Cheryl Pritlove
- Li Ka Shing Knowledge Institute, Unity Health, Toronto, Ontario, Canada; School of Kinesiology and Health Science, York University, Toronto, Ontario, Canada
| | - Dana Shearer
- Li Ka Shing Knowledge Institute, Unity Health, Toronto, Ontario, Canada; Ontario Drug Policy Research Network, Toronto, Ontario, Canada
| | - Diana Martins
- Li Ka Shing Knowledge Institute, Unity Health, Toronto, Ontario, Canada; Ontario Drug Policy Research Network, Toronto, Ontario, Canada
| | - Mina Tadrous
- Li Ka Shing Knowledge Institute, Unity Health, Toronto, Ontario, Canada; Ontario Drug Policy Research Network, Toronto, Ontario, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; Women's College Research Institute, Toronto, Ontario, Canada
| | - Charlotte Munro
- Ontario Drug Policy Research Network, Toronto, Ontario, Canada
| | - Tara Gomes
- Li Ka Shing Knowledge Institute, Unity Health, Toronto, Ontario, Canada; Ontario Drug Policy Research Network, Toronto, Ontario, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
| |
Collapse
|
10
|
Psychosocial factors associated with pharmacists' end-of-life medication counseling and dispensing. J Am Pharm Assoc (2003) 2021; 61:308-315. [PMID: 33568269 DOI: 10.1016/j.japh.2021.01.020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2020] [Revised: 12/23/2020] [Accepted: 01/12/2021] [Indexed: 01/03/2023]
Abstract
OBJECTIVE In 2015, California legalized physician-assisted suicide through passing the End of Life Option Act (ELOA). This study aimed to identify and describe the psychosocial factors associated with pharmacists' intention to counsel and dispense end-of-life medications. METHODS Data were collected using a 51-item questionnaire that was mailed to 2,000 registered community pharmacists in California. The study collected data on TPB constructs (attitude, subjective norm [SN], and perceived behavioral control [PBC]), behavioral and control beliefs, perceived obligation, and demographic and practice characteristics. Hierarchical linear regression was used to identify the factors associated with the pharmacists' intention. RESULTS A total of 353 responses (19.4% response rate) were received from respondents with an average age of 50.4 ± 14.8 years. Most of the respondents were women (53.1%) and religious (56.4%). Most pharmacies did not currently stock ELOA medications (n = 197, 56.1%), and most pharmacists had never been presented with an ELOA prescription in their practice (n = 319, 90.4%). The pharmacists had a positive intention (mean = 8.24 ± 4.6, range: 2-14), attitude (mean = 17.15 ± 6.9, range: 4-28), SN (mean = 1.1 ± 4.5; range: -9 to 9), and PBC (mean = 1.85 ± 3.5; range: -6 to 6) to dispense ELOA medications. Attitude (β = 0.570, P < 0.001), SN (β = 0.238, P < 0.001), and perceived obligation were statistically significant predictors of the pharmacists' intention to dispense ELOA medications for patients with a valid prescription but PBC (β = 0.022, P = 0.531) was not. CONCLUSION Interventions to promote pharmacists' counseling and dispensing of ELOA medications should focus on developing strong intention. Improving pharmacists' attitude, SN, and perceived obligation is critical to increasing their willingness to dispense ELOA medications.
Collapse
|
11
|
Witry MJ, Fadare O, Pudlo A. Pharmacy professionals' preparedness to use Mental Health First Aid (MHFA) behaviors. Pharm Pract (Granada) 2020; 18:2102. [PMID: 33294061 PMCID: PMC7699831 DOI: 10.18549/pharmpract.2020.4.2102] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Accepted: 10/25/2020] [Indexed: 11/17/2022] Open
Abstract
Background: There is a need to train healthcare professionals to provide first aid to
people experiencing a mental health crisis. Research testing the association
between Mental Health First Aid (MHFA) training and the use of MHFA
behaviors could provide evidence of program effectiveness in the pharmacy
setting. Objectives: The objectives of this study were to measure the preparedness of pharmacy
professionals to function in a MHFA role, and compare preparedness and the
use of MHFA behaviors based on demographic characteristics. Methods: Pharmacists and student pharmacists attended MHFA training under a
multi-state pharmacy initiative in 2018. An anonymous electronic survey was
administered to 227 participants using 4 contacts in May to June, 2019. The
survey evaluated if participants had recommended MHFA to others, their
preparedness to engage in MHFA behaviors (13 items), and their frequency of
performing a set of MHFA behaviors (7 items). Descriptive statistics,
bivariate analysis, and ANOVA were used to describe the sample and compare
these variables across groups. Results: The analysis was based on 96 responses (42.3%). Almost all respondents
(96%) had recommended MHFA training to others. Respondents reported
that the training program prepared them to provide a range of MHFA behaviors
for multiple mental health conditions, particularly for depression and
anxiety. Participants most often reported asking about a distressed mood and
listening non-judgmentally. Almost half of participants had asked someone if
they were considering suicide and a similar percent had referred someone
considering suicide to resources. Those reporting the highest levels of
preparedness engaged in significantly more MHFA behaviors than those with
lower levels of preparedness (p=0.017). Preparedness and use of MHFA
behaviors were not significantly associated with respondent demographic
characteristics. Conclusion: These data suggest that pharmacy professionals who had MHFA training felt
prepared to engage in MHFA and many used behaviors like asking about suicide
and making referrals since being trained in MHFA. Research is warranted to
better understand what makes someone feel maximally prepared to use MHFA
behaviors compared to lower feelings of preparedness.
Collapse
Affiliation(s)
- Matthew J Witry
- PharmD, PhD. Assistant Professor, Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa. Iowa City, IA (United States).
| | - Olajide Fadare
- BPharm. Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa. Iowa City, IA (United States).
| | - Anthony Pudlo
- PharmD, MBA. Vice President. Professional Affairs, Iowa Pharmacy Association. Des Moines, IA (United States).
| |
Collapse
|
12
|
Lauzier S, Guillaumie L, Humphries B, Grégoire JP, Moisan J, Villeneuve D. Reprint of: Psychosocial factors associated with pharmacists' antidepressant drug treatment monitoring. J Am Pharm Assoc (2003) 2020; 60:S34-S43. [PMID: 32977929 DOI: 10.1016/j.japh.2020.08.034] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2019] [Accepted: 01/09/2020] [Indexed: 02/06/2023]
Abstract
OBJECTIVE Patients undergoing antidepressant drug treatment (ADT) may face challenges regarding its adverse effects, adherence, and efficacy. Community pharmacists are well positioned to manage ADT-related problems. Little is known about the factors influencing pharmacists' ADT monitoring. This study aimed to identify the psychosocial factors associated with pharmacists' intention to perform systematic ADT monitoring and report on this monitoring. DESIGN Cross-sectional study based on the Theory of Planned Behavior (TPB). SETTING AND PARTICIPANTS Community pharmacists in the province of Quebec, Canada. OUTCOME MEASURES Pharmacists completed a questionnaire on their performance of ADT monitoring, TPB constructs (intention; attitude; subjective norm; perceived behavioral control; and attitudinal, normative, and control beliefs), and professional identity. Systematic ADT monitoring was defined as pharmacists' reporting 4 or more consultations with each patient during the first year of ADT to address adverse effects, adherence, and efficacy. Hierarchical linear regression models were used to identify the factors associated with the intention and reporting of systematic ADT monitoring and Poisson working models to identify the beliefs associated with intention. RESULTS A total of 1609 pharmacists completed the questionnaire (participation = 29.6%). Systematic ADT monitoring was not widely reported (mean score = 2.0 out of 5.0), and intention was moderate (mean = 3.2). Pharmacists' intention was the sole psychosocial factor associated with reporting systematic ADT monitoring (P < 0.0001; R2 = 0.370). All TPB constructs and professional identity were associated with intention (P < 0.0001; R2 = 0.611). Perceived behavioral control had the strongest association. CONCLUSION Interventions to promote systematic ADT monitoring should focus on developing a strong intention among pharmacists, which could, in turn, influence their practice. To influence intention, priority should be given to ensuring that pharmacists feel capable of performing this monitoring. The main barriers to overcome were the presence of only 1 pharmacist at work and limited time. Other factors identified offer complementary intervention targets.
Collapse
|
13
|
Witry M, Karamese H, Pudlo A. Evaluation of participant reluctance, confidence, and self-reported behaviors since being trained in a pharmacy Mental Health First Aid initiative. PLoS One 2020; 15:e0232627. [PMID: 32365115 PMCID: PMC7197798 DOI: 10.1371/journal.pone.0232627] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2019] [Accepted: 04/17/2020] [Indexed: 11/19/2022] Open
Abstract
In the U.S., an estimated one in five individuals experience a mental illness annually which contribute to significant human and economic cost. Pharmacists serving in a public health capacity are positioned to provide first aid level intervention to people experiencing a mental health crisis. Research on pharmacy professionals (pharmacists, technicians, students) undergoing training in Mental Health First Aid (MHFA) can provide evidence of the potential benefits of such training. The objectives of this study were to 1) describe the reluctance and confidence to intervene in mental health crises of pharmacy professionals previously trained in MHFA, 2) describe their self-reported use of MHFA behaviors since becoming trained, and 3) describe participant open-ended feedback on their MHFA training. Materials and methods: An electronic survey was disseminated in May and June, 2019 using a four-email sequence to pharmacy professionals who had completed MHFA training from one of five pharmacist MHFA trainers throughout 2018. Domains included demographics, six Likert-type reluctance items, seven Likert-type confidence items for performing MHFA skills, and frequency of using a set of nine MHFA skills since being trained. Prompts collected open-ended feedback related to MHFA experiences and training. Descriptive statistics were used for scaled and multiple-choice items and a basic content analysis was performed on the open-ended items to group them into similar topics. Results: Ninety-eight out of 227 participants responded to the survey yielding a response rate of 44%. Participants reported high levels of disagreement to a set of reluctance items for intervening and overall high levels of confidence in performing a range of MHFA skills. Participant self-reported use of a set of MHFA skills ranged from 19% to 82% since being trained in MHFA. Almost half (44%) of participants had asked someone if they were considering suicide. A majority (61%) also had referred someone to resources because of a mental health crisis. Open-ended responses included positive experiences alongside important challenges to using MHFA in practice and recommendations including additional training focused on the pharmacy setting. Conclusions: Pharmacy professionals in this evaluation reported little reluctance and high confidence related to using MHFA training and reported use of MHFA skills since being trained.
Collapse
Affiliation(s)
- Matthew Witry
- Division of Health Services Research, Department of Pharmacy Practice and Science, University of Iowa College of Pharmacy, Iowa City, Iowa, United States of America
- * E-mail:
| | - Hacer Karamese
- Center for Evaluation and Assessment, University of Iowa College of Education, Iowa City, Iowa, United States of America
| | - Anthony Pudlo
- Iowa Pharmacy Association, Des Moines, Iowa, United States of America
| |
Collapse
|
14
|
Mospan CM, Gillette C. Student Pharmacists' Attitudes Toward Suicide and the Perceived Role of Community Pharmacists in Suicidal Ideation Assessment. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION 2020; 84:7588. [PMID: 32577030 PMCID: PMC7298224 DOI: 10.5688/ajpe7588] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/06/2019] [Accepted: 10/14/2019] [Indexed: 05/30/2023]
Abstract
Objective. To determine first-year Doctor of Pharmacy students' attitudes toward suicide and perceptions of the role of the pharmacist in assessing patients for suicidal ideation, and whether their previous pharmacy work experience influences these attitudes and perceptions. Methods. An anonymous online survey was administered to first-year student pharmacists at one school of pharmacy in North Carolina. Measures included gender, previous community pharmacy work experience, personal contact with suicide, and score on the Attitudes Toward Suicide (ATTS) scale. Results. Seventy-three student pharmacists (75%) completed the survey. The vast majority (92%) agreed or strongly agreed that suicide was a real disease. Similarly, most students (79%) agreed or strongly agreed that pharmacists have a professional responsibility to assess for suicidal ideation. There was not a significant association between ATTS score and previous community pharmacy work experience nor the perceived pharmacist's role in assessing for suicidal ideation. Additionally, there was no association between ATTS score and personal contact with suicide. Conclusion. First-year student pharmacists, while undecided on their personal attitudes toward suicide, overwhelmingly agreed that suicide is a disease and that pharmacists have an important role in assessing patients for suicidal ideation. Pharmacy schools should implement training programs to prepare student pharmacists to identify suicidal ideation, design interventions to address student pharmacists' personal beliefs that may impact their ability to provide patient care, and provide students with adequate support skills to care for patients experiencing mental health crises.
Collapse
Affiliation(s)
| | - Chris Gillette
- Wake Forest School of Medicine, Winston-Salem, North Carolina
| |
Collapse
|
15
|
Mospan CM, Gillette C, Wilson JA. Patient and prescriber perceptions of depression screening within a community pharmacy setting. J Am Pharm Assoc (2003) 2020; 60:S15-S22. [PMID: 32280022 DOI: 10.1016/j.japh.2020.03.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2019] [Revised: 02/29/2020] [Accepted: 03/06/2020] [Indexed: 01/02/2023]
Abstract
OBJECTIVES To determine patient and prescriber perceptions of depression screening within the community pharmacy setting and to assess the best strategies for patient engagement and care coordination. DESIGN Qualitative semistructured key informant interviews using the Consolidated Framework for Implementation Research as a theoretical framework. SETTING AND PARTICIPANTS A community pharmacy in the metropolitan Piedmont region of North Carolina from February 2019 to May 2019. Prescriber and patient interviews were audio recorded, transcribed, and independently coded by 2 investigators. A qualitative analysis was completed, with a selection of supporting quotations for each theme. OUTCOME MEASURES Qualitative analysis of prescriber and patient perceptions of depression screening provided in community pharmacies, strategies for patient engagement, and coordination of care for depression screenings. RESULTS Twelve patients and 4 prescribers participated in the study. The patient perceptions were categorized into 3 key themes: (1) private and confidential screenings; (2) disparate views regarding the potential interventions that pharmacists could offer; and (3) mental health stigma concerns. The prescriber perceptions were categorized into 3 key themes: (1) support for expanded access to depression screenings provided in community pharmacies; (2) necessity of referral algorithms for transitions of care; and (3) communication of full screening results for positive and negative screens. A mutual theme was identified among patients and prescribers: the view that mental health care provided at a community pharmacy was influenced by an established relationship with a community pharmacist. CONCLUSION This study describes patient and provider perceptions of depression screening within the community pharmacy setting. Prescribers were supportive of community pharmacists' ability to close the gaps in access to care for patients with mental health conditions, whereas patients had mixed feelings that may have been influenced by concerns of privacy, confidentiality, and stigma. This deeper understanding of prescriber and patient perceptions of how community pharmacies could expand access to depression screening may provide a roadmap for offering these interventions in community pharmacies.
Collapse
|
16
|
Silvia RJ. A Music Assignment to Develop Pharmacy Students' Empathy Toward People with Opioid Use Disorder. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION 2020; 84:7631. [PMID: 32431313 PMCID: PMC7223934 DOI: 10.5688/ajpe7631] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2019] [Accepted: 09/06/2019] [Indexed: 06/11/2023]
Abstract
Objective. To determine the effectiveness of using music to assist pharmacy students in developing empathy toward patients with opioid use disorder. Methods. Students were given an extra credit assignment as part of an elective course in neuropsychiatry. Students were to listen to the autobiographical album, The Heroin Diaries Soundtrack, about the life of rock music star Nikki Sixx and his struggles with heroin addiction. They were then required to write a reflection about how the lyrics and music from the album affected their personal views on persons with opioid use disorder. Results. Eighteen of 25 students in the course completed the assignment. Students' response to the assignment was universally positive. Many commented on their previous views that opioid use was a choice and a problem for law enforcement to manage. Students stated how their perspectives changed significantly after listening to the music and developing an appreciation for the symptoms and problems related to opioid use disorder and attempts to abstain. Many students remarked how the musical accompaniment to the lyrics and narration helped shape their emotional response.Conclusion. Health professions students often have difficulty understanding mental illnesses, including substance use disorders. Music can be used to enhance student's empathy toward patients with mental health and substance use disorders. Music and other art forms may be especially useful when teaching subject matter related to the affective domain.
Collapse
|
17
|
McMillan SS, Stapleton H, Stewart V, Wheeler AJ, Kelly F. A qualitative study exploring opportunities for pharmacists to connect with young mental health consumers. J Am Pharm Assoc (2003) 2020; 60:S23-S33. [PMID: 32217083 DOI: 10.1016/j.japh.2020.02.018] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2019] [Revised: 11/28/2019] [Accepted: 02/13/2020] [Indexed: 10/24/2022]
Abstract
OBJECTIVE To explore how pharmacists can best support young people using medication for any mental health condition. The experiences of obtaining or supplying psychotropic medication and recommendations for service improvement were explored from the perspectives of young people, community pharmacists, and key stakeholders. DESIGN A qualitative study using semistructured interviews with young people and pharmacists and the nominal group technique as a consensus method for stakeholders. SETTING AND PARTICIPANTS Face-to-face interviews were conducted with 18 young people and a nominal group with 6 stakeholders at 1 of 2 mental health support organizations in Brisbane, Queensland, Australia. Phone conversations were held with 11 pharmacists who were located across Australia. The young people were aged between 14 and 25 years, had used a mental health medication for the previous 2 months, and lived in the community. Pharmacists recognized as mental health advocates or providing a mental health service and stakeholders from 1 support organization were purposively recruited. OUTCOME MEASURES Themes related to the current and potential roles for pharmacists when interacting with young people using psychotropic medication. RESULTS There was limited awareness of the role of pharmacists, possibly because of the largely transactional nature of the young people's pharmacy experiences. However, young people perceived value in receiving information from pharmacists about their psychotropic medication, in particular, their adverse effects, and interactions with alcohol and other recreational drugs. Respectful communication and access to a private space to discuss sensitive matters were ways that pharmacists could encourage the development of supportive relationships with young people. CONCLUSION This study provides unique insights about the experiences of young people using psychotropic medication within community pharmacies. There is an imperative for pharmacists to move beyond a transactional or reactive approach to create a safe health space and address young people's medication concerns beyond initial supply.
Collapse
|
18
|
Lauzier S, Guillaumie L, Humphries B, Grégoire JP, Moisan J, Villeneuve D. Psychosocial factors associated with pharmacists' antidepressant drug treatment monitoring. J Am Pharm Assoc (2003) 2020; 60:548-558. [PMID: 32173335 DOI: 10.1016/j.japh.2020.01.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2019] [Revised: 12/20/2019] [Accepted: 01/09/2020] [Indexed: 12/13/2022]
Abstract
OBJECTIVE Patients undergoing antidepressant drug treatment (ADT) may face challenges regarding its adverse effects, adherence, and efficacy. Community pharmacists are well positioned to manage ADT-related problems. Little is known about the factors influencing pharmacists' ADT monitoring. This study aimed to identify the psychosocial factors associated with pharmacists' intention to perform systematic ADT monitoring and report on this monitoring. DESIGN Cross-sectional study based on the Theory of Planned Behavior (TPB). SETTING AND PARTICIPANTS Community pharmacists in the province of Quebec, Canada. OUTCOME MEASURES Pharmacists completed a questionnaire on their performance of ADT monitoring, TPB constructs (intention; attitude; subjective norm; perceived behavioral control; and attitudinal, normative, and control beliefs), and professional identity. Systematic ADT monitoring was defined as pharmacists' reporting 4 or more consultations with each patient during the first year of ADT to address adverse effects, adherence, and efficacy. Hierarchical linear regression models were used to identify the factors associated with the intention and reporting of systematic ADT monitoring and Poisson working models to identify the beliefs associated with intention. RESULTS A total of 1609 pharmacists completed the questionnaire (participation = 29.6%). Systematic ADT monitoring was not widely reported (mean score = 2.0 out of 5.0), and intention was moderate (mean = 3.2). Pharmacists' intention was the sole psychosocial factor associated with reporting systematic ADT monitoring (P < 0.0001; R2 = 0.370). All TPB constructs and professional identity were associated with intention (P < 0.0001; R2 = 0.611). Perceived behavioral control had the strongest association. CONCLUSION Interventions to promote systematic ADT monitoring should focus on developing a strong intention among pharmacists, which could, in turn, influence their practice. To influence intention, priority should be given to ensuring that pharmacists feel capable of performing this monitoring. The main barriers to overcome were the presence of only 1 pharmacist at work and limited time. Other factors identified offer complementary intervention targets.
Collapse
|
19
|
Hall B, Kelly F, Wheeler AJ, McMillan SS. Consumer perceptions of community pharmacy-based promotion of mental health and well-being. Health Promot J Austr 2019; 32:26-31. [PMID: 31821666 DOI: 10.1002/hpja.312] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2019] [Revised: 11/22/2019] [Accepted: 12/03/2019] [Indexed: 11/12/2022] Open
Abstract
ISSUE ADDRESSED With nearly half of all Australians likely to experience a mental illness, increasing community-based mental health promotion is warranted. Community pharmacies are accessible health care destinations that effectively provide a range of public health services. This study explored consumer opinions of mental health promotion in the community pharmacy setting, the activities they have observed and the perceived role/s of pharmacy staff in this area. METHODS A survey was informed by five interviews with pharmacy consumers and a literature review. Adult pharmacy consumers were recruited nationwide via a Research Panel company between December 2018 and January 2019. Survey data were descriptively analysed and associations confirmed by chi-square analysis. RESULTS Data were analysed from 537 of the 577 respondents; 34.3% of participants had a lived experience of mental illness. Just under a quarter of participants (23.3%) had observed mental health promotion in community pharmacy. Pharmacy was viewed as a suitable environment for this promotion by most respondents (n = 446/516), particularly those with lived experience, with a preference for in-store leaflets, posters and linking with existing national mental health organisations/campaigns. Lack of privacy and the busy pharmacy environment were identified as barriers for promotion in this setting. CONCLUSION There is a clear potential for mental health promotion within community pharmacies, although the uptake and impact of such activities require further investigation. SO WHAT?: These findings highlight a missed opportunity for pharmacists to engage with consumers about mental health and well-being, even though community pharmacies are accessible health care destinations.
Collapse
Affiliation(s)
- Bethany Hall
- Quality Use of Medicines Network, School of Pharmacy and Pharmacology, Griffith University, Gold Coast, Queensland, Australia
| | - Fiona Kelly
- Quality Use of Medicines Network, School of Pharmacy and Pharmacology, Griffith University, Gold Coast, Queensland, Australia.,Menzies Health Institute Queensland, Griffith University, Brisbane, Queensland, Australia
| | - Amanda J Wheeler
- Menzies Health Institute Queensland, Griffith University, Brisbane, Queensland, Australia.,Faculty of Medical and Health Sciences, Auckland University, Auckland, New Zealand
| | - Sara S McMillan
- Quality Use of Medicines Network, School of Pharmacy and Pharmacology, Griffith University, Gold Coast, Queensland, Australia.,Menzies Health Institute Queensland, Griffith University, Brisbane, Queensland, Australia
| |
Collapse
|
20
|
Rickles N, Wertheimer A, Huang Y. Training Community Pharmacy Staff How to Help Manage Urgent Mental Health Crises. PHARMACY 2019; 7:pharmacy7030133. [PMID: 31527455 PMCID: PMC6789501 DOI: 10.3390/pharmacy7030133] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2019] [Revised: 09/05/2019] [Accepted: 09/07/2019] [Indexed: 11/16/2022] Open
Abstract
Nearly 44 million Americans are affected by mental illness every year. Many individuals, however, are not diagnosed and/or do not receive treatment. The present manuscript reviews the incidence of mental illness, the continuum from mental wellness to mental illness, and the role of the pharmacy staff in helping individuals manage different mental health needs. In particular, there is discussion of stigma of mental illness that those with mental health needs experience by those around them including health professionals such as pharmacy staff. One way to resolve such stigma is through training such as Mental Health First Aid (MHFA). The paper reviews key aspects of MHFA, the evidence supporting MHFA, and how MHFA relates specifically to pharmacy practice and services. A conceptual framework for MHFA and its relationship to individual factors, attitudes, behaviors, and outcomes. Lastly, a discussion is presented that briefly compares MHFA to other similar approaches to helping those in mental health crises, the limits of what is known about MHFA, and what future research might explore to better understand the outcomes of pharmacy staff providing mental health education, support, and referral to care.
Collapse
Affiliation(s)
- Nathaniel Rickles
- Department of Pharmacy Practice, University of Connecticut, Storrs, CT 06269, USA.
| | - Albert Wertheimer
- Department of Sociobehavioral and Administrative Pharmacy, Fort Lauderdale-Davie, FL 33314, USA.
| | - Yifan Huang
- Department of Pharmacy Practice, University of Connecticut, Storrs, CT 06269, USA.
| |
Collapse
|
21
|
Gillette C, Mospan CM, Benfield M. North Carolina community pharmacists' attitudes about suicide and willingness to conduct suicidal ideation assessment: A cross-sectional survey study. Res Social Adm Pharm 2019; 16:727-731. [PMID: 31416756 DOI: 10.1016/j.sapharm.2019.08.023] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2019] [Revised: 08/05/2019] [Accepted: 08/06/2019] [Indexed: 11/18/2022]
Abstract
BACKGROUND Suicide is a major and growing public health problem. Pharmacists are one of the most accessible members of the health care team. Due to their unique place in the health care system, pharmacists may be an ideal resource for monitoring patients at risk of suicide. The objectives of this study were to: (1) investigate community pharmacists' attitudes toward suicide; (2) identify pharmacist-reported barriers to suicidal ideation assessment; and (3) evaluate facilitators and barriers to pharmacists conducting suicidal ideation assessment. METHODS An anonymous questionnaire was distributed to North Carolina (NC) community pharmacists. Measures included contact with suicide, perceived role in suicidal ideation assessment, Attitudes Towards Suicide (ATTS), and barriers in suicidal ideation assessment. Multivariable logistic regression was used to analyze the data. RESULTS There were usable and complete data for 225 participants (3.52% response rate). The median ATTS score was 70 (IQR = 7). Community pharmacists were significantly more likely to perform a suicidal ideation assessment at least sometimes when (s)he reported a lower number of barriers (OR = 0.70, 99.5% CI = 0.51-0.98) and when (s)he agreed or strongly agreed that they knew how to help someone who was suicidal (OR = 6.63, 99.5% CI = 1.74, 25.23). The most common barrier to suicidal ideation assessment was lack of education in mental health screening (n = 176). CONCLUSIONS Suicide prevention education programs for pharmacists may need to address reducing barriers, increasing knowledge about suicide, and improving self-efficacy. Targeting these areas may lead more pharmacists conducting these assessments.
Collapse
Affiliation(s)
- Chris Gillette
- Department of PA Studies, Wake Forest School of Medicine, Winston-Salem, USA.
| | | | | |
Collapse
|
22
|
Ballou JM, Chapman AR, Roark AM, Huie CH, McKee J, Marciniak MW. Conducting depression screenings in a community pharmacy: A pilot comparison of methods. JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2019. [DOI: 10.1002/jac5.1156] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Jordan M. Ballou
- UNC Eshelman School of Pharmacy; University of North Carolina at Chapel Hill; Chapel Hill North Carolina
- Brame Huie Pharmacy; North Wilkesboro North Carolina
| | | | | | - Cathy H. Huie
- Brame Huie Pharmacy; North Wilkesboro North Carolina
| | - Jerry McKee
- Community Care of North Carolina; Raleigh North Carolina
| | - Macary W. Marciniak
- UNC Eshelman School of Pharmacy; University of North Carolina at Chapel Hill; Chapel Hill North Carolina
| |
Collapse
|
23
|
Providing mindfulness meditation for patients with depression and anxiety in a community pharmacy: A pilot study. J Am Pharm Assoc (2003) 2019; 59:258-264. [DOI: 10.1016/j.japh.2018.10.017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Revised: 10/25/2018] [Accepted: 10/26/2018] [Indexed: 12/11/2022]
|
24
|
Giannetti V, Caley CF, Kamal KM, Covvey JR, McKee J, Wells BG, Najarian DM, Dunn TJ, Vadagam P. Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs. Int J Clin Pharm 2018; 40:1096-1105. [PMID: 29862460 DOI: 10.1007/s11096-018-0619-7] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2017] [Accepted: 03/15/2018] [Indexed: 11/24/2022]
Abstract
Background Half of Americans experience mental illness during their lifetime. Significant opportunity exists for community pharmacists to deliver services to these patients; however, personal and practice-related barriers may prevent full engagement. Objective To assess the demographics, practice characteristics, service provision, stigma, attitudes and beliefs of a national sample of community pharmacists towards individuals with mental illness. Setting National random sample of 3008 community pharmacists in the USA. Method 101-item cross-sectional mailed survey questionnaire on: (1) demographics, (2) knowledge and practice characteristics, (3) provision of clinical pharmacy services, and (4) comparative opinions. Main outcome measure Scaled measures of service provision (comfort, confidence, willingness and interest) and comparative opinions (stigma, attitudes and beliefs) of mental illness, four linear regression models to predict service provision. Results A total of 239 responses were received (response rate 7.95%). Across pharmacy services, ratings for willingness/interest were higher than those for comfort/confidence. Pharmacists who reported providing medication therapy management (MTM) services for patients reported higher comfort (18.36 vs. 17.46, p < 0.05), confidence (17.73 vs. 16.01, p < 0.05), willingness (20.0 vs. 18.62, p < 0.05) and interest (19.13 vs. 17.66, p < 0.05). Pharmacists with personal experience with mental illness also resulted in higher scores across all four domains of service provision, lower levels of stigma (18.28 vs. 20.76, p < 0.05) and more positive attitudes (52.24 vs. 50.53, p < 0.01). Regression analyses demonstrated increased frequency of MTM service delivery and more positive attitudes as significantly predictive across all four models for comfort, confidence, willingness and interest. Increased delivery of pharmacy services was significantly associated with both willingness and interest to provide mental illness-specific services. Conclusion Despite willingness/interest to provide services to patients with mental illness, decreased levels of comfort/confidence remain service-related barriers for community pharmacists.
Collapse
Affiliation(s)
- Vincent Giannetti
- Division of Pharmaceutical, Administrative and Social Sciences, Duquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA, 15282, USA.
| | - Charles F Caley
- Department of Pharmacy Practice, Western New England University College of Pharmacy and Health Sciences, 1215 Wilbraham Road, Springfield, MA, 01119, USA
| | - Khalid M Kamal
- Division of Pharmaceutical, Administrative and Social Sciences, Duquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA, 15282, USA
| | - Jordan R Covvey
- Division of Pharmaceutical, Administrative and Social Sciences, Duquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA, 15282, USA
| | - Jerry McKee
- Community Care of North Carolina, 2300 Rexwoods Drive, Raleigh, NC, 27607, USA
| | - Barbara G Wells
- The University of Mississippi School of Pharmacy, University, MS, 38677, USA
| | - Dean M Najarian
- Janssen Scientific Affairs, 1771 West Street, Wrentham, MA, 02093, USA
| | - Tyler J Dunn
- The University of Mississippi School of Pharmacy, University, MS, 38677, USA
| | - Pratyusha Vadagam
- Envision Pharma Group, 205 East 42nd Street, New York, NY, 10017, USA
| |
Collapse
|
25
|
Barrett M, Keating A, Lynch D, Scanlon G, Kigathi M, Corcoran F, Sahm LJ. Clozapine Patients at the Interface between Primary and Secondary Care. PHARMACY 2018; 6:E19. [PMID: 29495370 PMCID: PMC5874558 DOI: 10.3390/pharmacy6010019] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2018] [Revised: 02/22/2018] [Accepted: 02/23/2018] [Indexed: 12/17/2022] Open
Abstract
Patients receiving clozapine must undergo routine blood monitoring to screen for neutropenia, and to monitor for potential agranulocytosis. In Cork University Hospital, Cork, Ireland, clozapine is dispensed in the hospital pharmacy and the pharmacists are not aware of co-prescribed medicines, potentially impacting upon patient safety. The aim of this study was to examine the continuity of care of patients prescribed clozapine. A retrospective audit was conducted on patients attending the clozapine clinic at Cork University Hospital and assessed patients' (i) independent living, (ii) co-prescribed medicines and (iii) knowledge of their community pharmacists regarding co-prescribed clozapine. A list of prescribed medicines for each patient was obtained, and potential drug-drug interactions between these medicines and clozapine were examined using Lexicomp® and Stockley's Interaction checker. Secondary outcomes included patients' physical health characteristics, and a review of co-morbidities. Data were collected between the 29 May 2017 and 20 June 2017. Local ethics committee approval was granted. Patients were eligible for inclusion if they were receiving clozapine treatment as part of a registered programme, were aged 18 years or more, and had the capacity to provide written informed consent. Microsoft Excel was used for data analysis. Of 112 patients, (33% female; mean age (SD) 43.9 (11.3) years; 87.5% living independently/in the family home) 86.6% patients reported that they were taking other prescribed medicines from community pharmacies. The mean (SD) number of co-prescribed medicines in addition to clozapine was 4.8 (4) per patient. Two thirds of community pharmacists were unaware of co-prescribed clozapine. Interactions with clozapine were present in all but 3 patients on co-prescribed medicines (n = 97). Lexicomp® reported 2.9 drug-drug interactions/patient and Stockley's Interaction Checker reported 2.5 drug-drug interactions/patient. Secondary outcomes for patients included BMI, total cholesterol, and HbA1c levels, which were elevated in 75%, 54% and 17% respectively. Patients prescribed clozapine did not receive a seamless service, between primary and secondary care settings. Community pharmacists were not informed of clozapine, prescribed for their patients, in two thirds of cases. Patients in this study were exposed to clozapine-related drug-drug interactions and hence potential adverse effects. This study supports reports in the literature of substandard management of the physical health of this patient group. This study shows that there is an opportunity for pharmacists to develop active roles in the management of all clozapine-related effects, in addition to their traditional obligatory role in haematological monitoring. This study supports the need for a clinical pharmacist to review inpatients commencing on clozapine, monitor for drug-drug interactions and provide counselling.
Collapse
Affiliation(s)
- Marita Barrett
- Pharmacy Department, Cork University Hospital, Cork T12 DC4A, Ireland.
| | - Anna Keating
- Pharmacy Department, Cork University Hospital, Cork T12 DC4A, Ireland.
| | - Deirdre Lynch
- Pharmacy Department, Cork University Hospital, Cork T12 DC4A, Ireland.
| | - Geraldine Scanlon
- Adult Mental Health Unit, Cork University Hospital, Cork T12 DC4A, Ireland.
| | - Mary Kigathi
- Adult Mental Health Unit, Cork University Hospital, Cork T12 DC4A, Ireland.
| | - Fidelma Corcoran
- Adult Mental Health Unit, Cork University Hospital, Cork T12 DC4A, Ireland.
| | - Laura J Sahm
- School of Pharmacy, University College Cork, Cork T12 YN60, Ireland.
- Pharmacy Department, Mercy University Hospital, Cork T12 WE28, Ireland.
| |
Collapse
|